Robert B. Bazemore - Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert B. Bazemore since 4/23/2024

Holdings reported by Robert B. Bazemore for Akari Therapeutics Plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 44.6K $50K $1.12 Mar 20, 2025 Direct
Series A Warrants (Right to Buy) 44.6K $50K $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy) 44.6K $50K $1.12 Mar 6, 2025 Direct American Depositary Shares representing Ordinary Shares
Stock Option (Right to Buy) 225K Mar 20, 2025 Direct American Depositary Shares representing Ordinary Shares

Transactions reported by Robert B. Bazemore for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.